



Course Contents:
Introduction & Basic technologies
Concepts of immunology in human
Human diseases
Genetic basis of diseases
Immune Pathogenesis
Microbial Pathogenesis
Modulating Gene Expression
Cell and tissue engineering
Molecular diagnostics
Protein Therapeutics
Nucleic acid therapeutic agents and human gene therapy
Vaccines development
BASIC OVERVIEW ON MEDICAL BIOTECHNOLOGY
Medical biotechnology is defined as the application of biotechnological tools and techniques in which the use of living cells, tissue, organs, or bodies to research and produce diagnostic and pharmaceutical products that can be used for the diagnosis, prevention, and treatment of diseases.
21st century is the fast-growing time of medical biotechnology. Many national and international companies, research institutes, government bodies are taking an interest in research and development in medical biotechnology.
Medical biotechnology plays critical roles during emerging of new chronic diseases either microbial or non-microbial. One of the best examples of Ebola disease and its causing agent is the Ebola virus. The first drug of Ebola disease is ZmappTm which is developed by Mapp pharmaceuticals corporation and Bioleaf corporation. Both are international biotech companies.
Medical biotechnology is related to our health, development of new drugs, work against bacterial, fungal, viral, cancer diseases, and so on.
Simpal Kumar Suman- Founder-Director at Biotechticle Research Group | Biotechnologist | Mathematical Biologist | Molecular Biologist | Bio-modeller | Molecular Data Analyst | Python-C++R- Programmer | Scientific Writer | Bio-IT
CGTCAGAGGCACGTCAACATCTTAAAGATGGCACTTG
CTTAGTAGAAGTTGAAAAAGGCGTTTTGCCTCAACTTGAACAGCCCTATGTGTTCATCAAACGTTCGGAT
GCTCGAACTGCACCTCATGGTCATGTTATGGTTGAGCTGGTAGCAGAACTCGAAGGCATTCAGTACGGTC
GTAGTGGTGAGACACTTGGTGTCCTTGTCCCTCATGTGGGCGAAATACCAGTGGCTTACCGCAAGGTTCT
CGTCAGAGGCACGTCAACATCTTAAAGATGGCACTTG
CTTAGTAGAAGTTGAAAAAGGCGTTTTGCCTCAACTTGAACAGCCCTATGTGTTCATCAAACGTTCGGAT
GCTCGAACTGCACCTCATGGTCATGTTATGGTTGAGCTGGTAGCAGAACTCGAAGGCATTCAGTACGGTC
GTAGTGGTGAGACACTTGGTGTCCTTGTCCCTCATGTGGGCGAAATACCAGTGGCTTACCGCAAGGTTCT